{"schema_version":"alpha-profile-public-v1","slug":"janneke-van-der-kamp","canonical_url":"https://registry.alpha.ac/people/janneke-van-der-kamp","as_of":"2026-09-21T23:12:15.796318+00:00","published_at":"2026-09-02T02:37:24.535783+00:00","last_reviewed_at":"2026-05-16T01:19:25.03+00:00","identity":{"display_name":"Janneke van der Kamp","headshot_url":null,"headshot_media":null,"profile_kind":"director","role_tags":["director","executive"],"current_role":{"company_name":"NewAmsterdam Pharma Co N.V.","company_slug":"newamsterdam-pharma-co-n-v","exchange":"NASDAQ","ticker":"NAMSW","role_category":"director","title":"Director","committee":null,"is_board_chair":false,"is_independent":true,"valid_from":"2023-01-01","valid_to":null,"is_current":true,"verification_status":"confirmed","confidence":0.85,"evidence":{"source_type":"sec_proxy","source_url":"https://www.sec.gov/Archives/edgar/data/1936258/000119312525115995/d904380ddef14a.htm","effective_date":"2025-05-08","last_checked_at":"2026-04-28T23:21:02.969+00:00"}},"photo_match":null},"assurance":{"is_claimed":false,"status":"unverified","assurance_level":null,"method":null,"verified_at":null,"expires_at":null},"claiming":{"eligible":true,"label":"Is this you? Claim your Alpha Profile","claim_url":"https://terminal.alpha.ac/claim-profile?person=janneke-van-der-kamp","suggest_edit_label":"Suggest an edit","suggest_edit_url":"https://terminal.alpha.ac/claim-profile?person=janneke-van-der-kamp&mode=suggest","canonical_record_will_be_reused":true,"canonical_facts_owner_controlled":false},"presentation":{"schema_version":"alpha-profile-presentation-v1","state":"alpha_editorial","version":0,"published_at":null,"headline":null,"headline_evidence":null,"location":null,"photo":null,"cover":null,"about":["Janneke van der Kamp has served as a member of the Board since April 2023. She currently serves as Chief Executive Officer of Norgine and previously served as Chief Commercial Officer of Grünenthal. She spent two decades at Novartis in roles of increasing responsibility, ultimately serving on the Pharma Executive Committee."],"links":[],"sources":[],"featured":[],"competencies":[],"board_preferences":null,"board_service":[{"organization":"NewAmsterdam Pharma Co N.V.","organizationId":"newamsterdam-pharma-co-n-v","title":"Director","period":"2023-01-01 · current","evidenceLabel":"sec_proxy","evidenceState":"verified","sourceUrl":"https://www.sec.gov/Archives/edgar/data/1936258/000119312525115995/d904380ddef14a.htm"}],"experience":[],"education":[],"credentials":[],"section_order":null,"hidden_sections":[],"limitations":["Presentation fields do not alter independently verified Alpha Profile facts.","Owner-supplied résumé records retain their field-level evidence state.","Only confirmed company_person_roles with public evidence. Website governed_site_fallback rows are not invented. about/links are stored people.profile_summary/bio and linkedin_url only. Dates stay undisclosed when the role has no start_date. SoFi Bank is not SoFi Technologies."]},"presentation_authority":"confirmed_company_person_roles","roles":[{"company_name":"NewAmsterdam Pharma Co N.V.","company_slug":"newamsterdam-pharma-co-n-v","exchange":"NASDAQ","ticker":"NAMSW","role_category":"director","title":"Director","committee":null,"is_board_chair":false,"is_independent":true,"valid_from":"2023-01-01","valid_to":null,"is_current":true,"verification_status":"confirmed","confidence":0.85,"evidence":{"source_type":"sec_proxy","source_url":"https://www.sec.gov/Archives/edgar/data/1936258/000119312525115995/d904380ddef14a.htm","effective_date":"2025-05-08","last_checked_at":"2026-04-28T23:21:02.969+00:00"}}],"claims":[{"claim_type":"ai_ml_experience","claim_value":false,"claim_text":"Proxy extraction classified AI/ML experience for Janneke van der Kamp as false.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.72,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-16T01:19:25.188334+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"NAMS DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1936258/000119312525115995/d904380ddef14a.htm","published_at":"2025-05-08T00:00:00+00:00","last_checked_at":"2026-05-16T01:19:25.085439+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"board_role","claim_value":"Director","claim_text":"Janneke van der Kamp currently serves as Director at NewAmsterdam Pharma Co N.V..","claim_state":"verified","valid_from":"2025-05-08","valid_to":null,"confidence":0.92,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-16T01:19:25.155175+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"NAMS DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1936258/000119312525115995/d904380ddef14a.htm","published_at":"2025-05-08T00:00:00+00:00","last_checked_at":"2026-05-16T01:19:25.085439+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"committee_assignments","claim_value":[],"claim_text":"Janneke van der Kamp serves on no disclosed committees.","claim_state":"verified","valid_from":"2025-05-08","valid_to":null,"confidence":0.88,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-16T01:19:25.172536+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"NAMS DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1936258/000119312525115995/d904380ddef14a.htm","published_at":"2025-05-08T00:00:00+00:00","last_checked_at":"2026-05-16T01:19:25.085439+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"current_executive_company","claim_value":"Norgine","claim_text":"Janneke van der Kamp is linked to Norgine as an operating executive.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.85,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-16T01:19:25.286093+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"NAMS DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1936258/000119312525115995/d904380ddef14a.htm","published_at":"2025-05-08T00:00:00+00:00","last_checked_at":"2026-05-16T01:19:25.085439+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"current_executive_role","claim_value":"Chief Executive Officer","claim_text":"Janneke van der Kamp is also listed as Chief Executive Officer.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.85,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-16T01:19:25.268768+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"NAMS DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1936258/000119312525115995/d904380ddef14a.htm","published_at":"2025-05-08T00:00:00+00:00","last_checked_at":"2026-05-16T01:19:25.085439+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"cybersecurity_experience","claim_value":false,"claim_text":"Proxy extraction classified cybersecurity experience for Janneke van der Kamp as false.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.72,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-16T01:19:25.220901+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"NAMS DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1936258/000119312525115995/d904380ddef14a.htm","published_at":"2025-05-08T00:00:00+00:00","last_checked_at":"2026-05-16T01:19:25.085439+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"technology_background","claim_value":false,"claim_text":"Proxy extraction classified technology background for Janneke van der Kamp as false.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.72,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-16T01:19:25.204865+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"NAMS DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1936258/000119312525115995/d904380ddef14a.htm","published_at":"2025-05-08T00:00:00+00:00","last_checked_at":"2026-05-16T01:19:25.085439+00:00","relation":"supports","excerpt_locator":null}]},{"subject":"alpha:person:janneke-van-der-kamp","claim_type":"board_service","claim_value":{"tags":[],"title":"Director","period":"2023-01-01 · current","organization":"NewAmsterdam Pharma Co N.V.","organization_id":"newamsterdam-pharma-co-n-v"},"claim_text":"Director at NewAmsterdam Pharma Co N.V. (2023-01-01 · current)","valid_from":null,"valid_to":null,"verification_status":"confirmed","date_precision":"period_text_only","evidence":[{"source_url":"https://www.sec.gov/Archives/edgar/data/1936258/000119312525115995/d904380ddef14a.htm","label":"sec_proxy","evidence_state":"verified"}],"claim_state":"confirmed","version":1}],"network":{"schema_version":"alpha-profile-network-public-v1","relationships":[],"relationship_pathfinding":false,"authentication_prompt":"Sign in to see how you're connected.","limitations":["Representative factual associations only.","Shared contexts do not assert personal acquaintance.","Anonymous graph traversal is not available."]},"permissions":{"classification":"open_public_projection","public_retrieval":true,"agent_retrieval":true,"redistribution":false,"model_training":false,"relationship_pathfinding":false,"direct_contact":false},"limitations":["Only permissioned public claims and evidence are included.","Absence of a claim is not evidence that the underlying fact is false.","Public retrieval does not grant model-training or redistribution rights.","Private relationships and Council activity are excluded."],"structured_data":{"@context":"https://schema.org","@type":"ProfilePage","@id":"https://registry.alpha.ac/people/janneke-van-der-kamp#profile","url":"https://registry.alpha.ac/people/janneke-van-der-kamp","dateModified":"2026-05-16T01:19:25.03+00:00","mainEntity":{"@type":"Person","@id":"https://registry.alpha.ac/people/janneke-van-der-kamp#person","name":"Janneke van der Kamp","url":"https://registry.alpha.ac/people/janneke-van-der-kamp","jobTitle":"Director","worksFor":{"@type":"Organization","name":"NewAmsterdam Pharma Co N.V.","tickerSymbol":"NASDAQ: NAMSW"},"affiliation":[{"@type":"OrganizationRole","roleName":"Director","startDate":"2023-01-01","memberOf":{"@type":"Organization","name":"NewAmsterdam Pharma Co N.V.","url":"https://registry.alpha.ac/companies/newamsterdam-pharma-co-n-v","tickerSymbol":"NASDAQ: NAMSW"}}]},"isBasedOn":[{"@type":"CreativeWork","url":"https://www.sec.gov/Archives/edgar/data/1936258/000119312525115995/d904380ddef14a.htm","name":"NAMS DEF 14A director slate"}],"mainEntityOfPage":"https://registry.alpha.ac/people/janneke-van-der-kamp"},"trust":{"schema_version":"alpha-profile-trust-v1","verification":{"schema_version":"alpha-verification-states-v1","state":"source_reported","identity_ownership":"unclaimed","assurance_level":null,"claim_state_counts":{"source_reported":9,"corroborated":0,"alpha_verified":0,"disputed":0,"superseded":0},"derivation":"claim_states+identity_ownership","summary":"Published claims are reported by public sources; none is Alpha verified. Profile ownership is unclaimed."},"aggregation":{"schema_version":"alpha-claim-aggregation-v1","published_claim_count":9,"under_review_claim_count":0,"owner_supplied_claim_count":0,"evidence_record_count":3,"distinct_source_count":1,"conflicts":[],"conflict_count":0,"headline_conflict_count":0,"internal_review_conflict_count":0,"contradiction_types":[],"headline_conflict_types":[],"verification":{"schema_version":"alpha-verification-states-v1","state":"source_reported","identity_ownership":"unclaimed","assurance_level":null,"claim_state_counts":{"source_reported":9,"corroborated":0,"alpha_verified":0,"disputed":0,"superseded":0},"derivation":"claim_states+identity_ownership","summary":"Published claims are reported by public sources; none is Alpha verified. Profile ownership is unclaimed."},"coverage":{"schema_version":"alpha-coverage-metric-v1","published_claims":9,"corroborated_claims":0,"sources":3,"distinct_sources":1,"role_claims":1,"last_reviewed_at":"2026-05-16T01:19:25.03+00:00","observed_at":"2026-09-21T23:12:15.796318+00:00","freshness_days":129}},"rights":{"public_retrieval":"allowed","agent_retrieval":"allowed","redistribution":"not_granted","model_training":"not_granted","commercial_use":"not_specified","relationship_pathfinding":"not_granted","direct_contact":"not_granted"}},"projection":{"schema_version":"alpha-profile-projection-v5","entity":{"kind":"person","slug":"janneke-van-der-kamp","canonical_url":"https://registry.alpha.ac/people/janneke-van-der-kamp"},"publication":{"published_at":"2026-09-02T02:37:24.535783+00:00","last_reviewed_at":"2026-05-16T01:19:25.03+00:00","as_of":"2026-09-21T23:12:15.796318+00:00"},"representations":{"html":{"href":"https://registry.alpha.ac/people/janneke-van-der-kamp","media_type":"text/html"},"json":{"href":"https://registry.alpha.ac/api/public/profiles/janneke-van-der-kamp","media_type":"application/json"},"markdown":{"href":"https://registry.alpha.ac/people/janneke-van-der-kamp.md","media_type":"text/markdown"},"structured_data":{"embedded":true,"media_type":"application/ld+json"},"share_image":null},"permissions":{"public_retrieval":true,"agent_retrieval":true,"redistribution":false,"model_training":false,"relationship_pathfinding":false,"direct_contact":false}}}